ARTICLE | Clinical News
Taspoglutide: Phase III started
August 11, 2008 7:00 AM UTC
Roche began an international Phase III program consisting of multiple trials comparing injectable taspoglutide to Byetta exenatide, Januvia sitagliptin or Lanthus insulin glargine in about 3,400 pat...